Diagnosis and treatment of diabetic foot ulcer complicated with lower extremity vasculopathy : Consensus recommendation from the Chinese Medical Association (CMA), Chinese Medical Doctor Association (CMDA)
© 2024 The Authors. Diabetes/Metabolism Research and Reviews published by John Wiley & Sons Ltd..
Diabetic foot ulcer complicated with lower extremity vasculopathy is highly prevalent, slow healing and have a poor prognosis. The final progression leads to amputation, or may even be life-threatening, seriously affecting patients' quality of life. The treatment of lower extremity vasculopathy is the focus of clinical practice and is vital to improving the healing process of diabetic foot ulcers. Recently, a number of clinical trials on diabetic foot ulcers with lower extremity vasculopathy have been reported. A joint group of Chinese Medical Association (CMA) and Chinese Medical Doctor Association (CMDA) expert representatives reviewed and reached a consensus on the guidelines for the clinical diagnosis and treatment of this kind of disease. These guidelines are based on evidence from the literature and cover the pathogenesis of diabetic foot ulcers complicated with lower extremity vasculopathy and the application of new treatment approaches. These guidelines have been put forward to guide practitioners on the best approaches for screening, diagnosing and treating diabetic foot ulcers with lower extremity vasculopathy, with the aim of providing optimal, evidence-based management for medical personnel working with diabetic foot wound repair and treatment.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
|---|---|
| Enthalten in: |
Diabetes/metabolism research and reviews - 40(2024), 3 vom: 24. Feb., Seite e3776 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wang, Kejia [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 26.02.2024 Date Revised 26.02.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1002/dmrr.3776 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368924300 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368924300 | ||
| 003 | DE-627 | ||
| 005 | 20240229155922.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240229s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/dmrr.3776 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1306.xml |
| 035 | |a (DE-627)NLM368924300 | ||
| 035 | |a (NLM)38402455 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wang, Kejia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Diagnosis and treatment of diabetic foot ulcer complicated with lower extremity vasculopathy |b Consensus recommendation from the Chinese Medical Association (CMA), Chinese Medical Doctor Association (CMDA) |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 26.02.2024 | ||
| 500 | |a Date Revised 26.02.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024 The Authors. Diabetes/Metabolism Research and Reviews published by John Wiley & Sons Ltd. | ||
| 520 | |a Diabetic foot ulcer complicated with lower extremity vasculopathy is highly prevalent, slow healing and have a poor prognosis. The final progression leads to amputation, or may even be life-threatening, seriously affecting patients' quality of life. The treatment of lower extremity vasculopathy is the focus of clinical practice and is vital to improving the healing process of diabetic foot ulcers. Recently, a number of clinical trials on diabetic foot ulcers with lower extremity vasculopathy have been reported. A joint group of Chinese Medical Association (CMA) and Chinese Medical Doctor Association (CMDA) expert representatives reviewed and reached a consensus on the guidelines for the clinical diagnosis and treatment of this kind of disease. These guidelines are based on evidence from the literature and cover the pathogenesis of diabetic foot ulcers complicated with lower extremity vasculopathy and the application of new treatment approaches. These guidelines have been put forward to guide practitioners on the best approaches for screening, diagnosing and treating diabetic foot ulcers with lower extremity vasculopathy, with the aim of providing optimal, evidence-based management for medical personnel working with diabetic foot wound repair and treatment | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a bypass surgery | |
| 650 | 4 | |a debridement | |
| 650 | 4 | |a diabetic foot ulcer | |
| 650 | 4 | |a endovascular therapy | |
| 650 | 4 | |a lower extremity vasculopathy | |
| 650 | 4 | |a microcirculation disturbance | |
| 650 | 7 | |a 4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid |2 NLM | |
| 650 | 7 | |a 122665-73-0 |2 NLM | |
| 650 | 7 | |a Glutamates |2 NLM | |
| 650 | 7 | |a Nitrogen Mustard Compounds |2 NLM | |
| 700 | 1 | |a Wang, Yunchuan |e verfasserin |4 aut | |
| 700 | 1 | |a Shi, Wenlong |e verfasserin |4 aut | |
| 700 | 1 | |a Shen, Kuo |e verfasserin |4 aut | |
| 700 | 1 | |a Tao, Ke |e verfasserin |4 aut | |
| 700 | 1 | |a Ling, Rui |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Yuesheng |e verfasserin |4 aut | |
| 700 | 1 | |a Fu, Xiaobing |e verfasserin |4 aut | |
| 700 | 1 | |a Hu, Dahai |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Diabetes/metabolism research and reviews |d 1999 |g 40(2024), 3 vom: 24. Feb., Seite e3776 |w (DE-627)NLM102947112 |x 1520-7560 |7 nnns |
| 773 | 1 | 8 | |g volume:40 |g year:2024 |g number:3 |g day:24 |g month:02 |g pages:e3776 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/dmrr.3776 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 40 |j 2024 |e 3 |b 24 |c 02 |h e3776 | ||